Sharing what we learn
Scientific contributions and outreach from the ERAMET consortium: published research, workshop highlights, conferences and training.
Welcome to the Dissemination hub, where we share the scientific contributions and outreach efforts of the ERAMET consortium. Here you will find published research papers, workshop highlights, and details of conferences and activities showcasing ERAMET’s progress and impact.
Our partners are committed to promoting the project’s work and engaging with the broader scientific and medical communities. Stay connected to learn about our latest findings and the events driving innovation in medicine development for rare and paediatric diseases.
Activities
ERAMET Project Open Day Activities: Get involved!
Oct 2025
XVII Foresight training Course | From research to access: how does Europe speed up the availability of medicines for unmet needs? | 3-4 November | Online
Jun 2025
ERAMET at PAGE 2025 in Thessaloniki: Advancing Model-Informed Drug Development in Paediatrics and Rare Diseases
Apr 2025
ERAMET Consortium Gathers at Face-to-Face Meeting at the University of Warwick
Sept 2024
Kick-Off of the ERAMET Project: A New Era for Paediatric Medicines Development
Science
The study of monoclonal antibodies for moderate-to-severe asthma examines how modelling and simulation have supported their development and regula…
A review of six authorised CAR-T therapies examines how modelling and simulation have supported their development and regulatory approval in Europe…
An ERAMET-supported review examines how modelling and simulation are used in medicine development for sickle cell disease and thalassaemia. Drawing…
A five-year review of EMA Scientific Advice explores how concentration-QT modelling can support cardiac safety assessments and requests to waive de…
A recent study comparing SIMCYP and PK-Sim shows how differences between modelling platforms can lead to clinically relevant variations in predicte…
A new study explores how modelling and simulation can support the development of antibiotics for children using ceftriaxone as a case study to hig…
